Q1: Drug A is a small and hydrophilic compound that distributes to extracellular fluids only. It has a volume of distribution of 5.6 L in a healthy 70-kg.

Slides:



Advertisements
Similar presentations
PHARMACOKINETIC.
Advertisements

Assignment 6 Metabolism
Pharmacokinetics Ampicillin Ceftriaxone Vancomycin Half-Life: hr
DISPOSITION OF DRUGS The disposition of chemicals entering the body (from C.D. Klaassen, Casarett and Doull’s Toxicology, 5th ed., New York: McGraw-Hill,
Module 2 # 2 Pharmacokinetics absorption of drugs drugs can be given iv, im, sc, orally (po) if given parenterally, they should.
Pharmacokinetics Questions
Nonlinear pharmacokinetics
One-compartment open model: Intravenous bolus administration
Renal Clearance The renal clearance of a substance is the volume of plasma that is completely cleared of the substance by the kidneys per unit time.
Practical Pharmacokinetics
Practical Pharmacokinetics September 11, 2007 Frank F. Vincenzi.
Pharmacokinetics Based on the hypothesis that the action of a drug requires presence of a certain concentration in the fluid bathing the target tissue.
Dose Adjustment in Renal and Hepatic Disease
Excretion of Drugs By the end of this lecture, students should be able to Identify main and minor routes of Excretion including renal elimination and biliary.
VM 8314 Dr. Jeff Wilcke Pharmacokinetic Modeling (describing what happens)
CLEARANCE CONCEPTS Text: Applied Biopharm. & PK
Quantitative Pharmacokinetics
The General Concepts of Pharmacokinetics and Pharmacodynamics Hartmut Derendorf, PhD University of Florida.
PHARMACOKINETICS 1. Fate of drugs in the body 1.1 absorption
Nonlinear Pharmacokinetics
Pharmacokinetics Introduction
From A Physiologic Perspective Chemical Clearance from the Body
PLASMA HALF LIFE ( t 1/2 ).  Minimum Effective Concentration (MEC): The plasma drug concentration below which a patient’s response is too small for clinical.
BASIC PHARMACOKINETIC PARAMETERS. PHARMACOKINETICS Pharmacokinetics is the study of the time course of a drug within the body and incorporates the processes.
The General Concepts of Pharmacokinetics and Pharmacodynamics
1 Single-dose kinetics Plasma [Drug] curve Upon administration [drug] plasma reaches a max Then begins to decline as the Drug is eliminated Cp max = max.
Noncompartmental Models. Introduction The noncompartmental approach for data analysis does not require any specific compartmental model for the system.
Clearance Determinations Arthur G. Roberts. Routes of Elimination.
PHARMACOKINETICS INTRODUCTION
Continuous intravenous infusion (one-compartment model)
Excretion of Drugs By the end of this lecture, students should be able to Identify main and minor routes of Excretion including renal elimination and biliary.
Pharmacology Department
MS Phoenix WinNonLin Project
Renal Clearance. Renal clearance : It is the volume of plasma that is completely cleared of the substance by the kidneys per unit time. Renal clearance.
Lecture 2 Clearance, maintenance dose and AUC
The General Concepts of Pharmacokinetics and Pharmacodynamics
Time Plasma Conc (hr) (mg/L) Below limit of detection 1 Compartment IV Analysis & Renal Elimination 500 mg of tobramycin.
Clearance: basic concept (in vitro) Update OCT 2010.
Pharmacokinetics 2 General Pharmacology M212
Learning objectives To know what data is available from pharmacokinetic studies in man and how to handle it To know how to calculate the basic pharmacokinetic.
DOSAGE ADJUSTMENT IN RENAL AND HEPATIC DISEASES Course Title : Biopharmaceutics and Pharmacokinetics – II Course Teacher : Zara Sheikh.
Intrinsic Clearance Arthur G. Roberts. Hydrophobic vs. Hydrophilic more bound to plasma proteins more distributed throughout body more metabolized.
Allie punke Pharmacokinetics tutoring Fall 2016
Pharmacokinetics.
Pharmacology Phone Number: (203)
Allie punke Pharmacokinetics tutoring Fall 2016
Lecture-8 Biopharmaceutics
Allie punke Pharmacokinetics tutoring Fall 2016
Pharmacokinetic Modeling (describing what happens)
Pharmacokinetics.
PHARMACOKINETICS Allie punke
Pharmacokinetics.
Dosing Regimen Concepts: 2-C, MM, Individualization principles
Pharmacokinetics.
Lab-3 practical pharmacology
Quantitative Pharmacokinetics
Pharmacokinetics.
affected by their interaction with protein
Clinical Pharmacokinetics
Therapeutic Drug Monitoring
Hawler Medical University
Selected Bioavailability and Pharmacokinetic Calculations
Biopharmaceutics Chapter-6
Principle of Basic Clinical Pharmacokinetic parameters
Introduction to Pharmacology
1-C: Renal and Hepatic Elimination
BIOAVAILABILITY.
Therapeutic Drug Monitoring
REFERENCE: APPLIED CLINICAL Slideshow by: lecturer HADEEL DELMAN
REFERENCE: APPLIED CLINICAL Slideshow by: lecturer HADEEL DELMAN
Presentation transcript:

Q1: Drug A is a small and hydrophilic compound that distributes to extracellular fluids only. It has a volume of distribution of 5.6 L in a healthy 70-kg person . The free fraction of the drug in plasma is 0.1. What is the free fraction of the drug in the tissues? fu = 0.1 VT = 13 L fuT = 0.5 1 1

Drug A (100 mg) is intravenously injected to a patient Drug A (100 mg) is intravenously injected to a patient. The AUC of plasma drug concentration vs. time curve is 20 mg/ml·h. Drug A is eliminated via hepatic metabolism and renal excretion only, and the fraction of the unchanged drug excreted in urine is 0.3. What is the total body clearance (CLT), hepatic clearance (CLH) and renal clearance (CLR) of drug A? CLT = Dose/AUC = 100 X 103 mg / (20 mg/ml·h) = 5 L/h CLR = fe · CL = 0.3 X 5 L/h = 1.5 L/h CLH = CLT - CLR = 3.5 L/h EH= CLH/QH = (3.5 L/h)/(1.35 L/min) = (3.5 L/h)/(81 L/h) = 0.043

In an average 70-kg adult, Drug B has a hepatic blood clearance of 1 In an average 70-kg adult, Drug B has a hepatic blood clearance of 1.2 L/min and is 95% bound to plasma protein. What is the new hepatic blood clearance of drug B, (a) if the plasma protein binding of the drug is decreased to 90%? (b) if the hepatic blood flow is decreased to 1.2 L/min? a. CLH = 1.2 L/min, fu = 0.05, Q = 1.35 L/min EH= CLH/QH = (1.2 L/min)/(1.35 L/min) = 0.89 Drug B is a high extraction ratio drug. The hepatic clearance of drug A is insensitive to changes in plasma protein binding. fu’=0.1 CLH’≈ 1.2 L/min b. CLH’ = QH’  EH = 1.2 L/min x 0.89 = 1.07 L/min

CLH = 10 ml/min, fu = 0.05, Q = 1.35 L/min In an average 70-kg adult, Drug C has a hepatic blood clearance of 10 ml/min and is 95% bound to the plasma protein. What is the new hepatic blood clearance of drug C (a) if the plasma protein binding of the drug is decreased to 90% ? (b) if the hepatic blood flow is decreased to 1.2 L/min? a. CLH = 10 ml/min, fu = 0.05, Q = 1.35 L/min EH= CLH/Q = (10 ml/min)/(1.35 L/min) = 0.007 Drug C is a low extraction ratio drug. CLint ≈ CLH/fu = (10 ml/min)/0.05 = 200 ml/min fu’ = 0.1 CLH’ ≈ fu’ CLint = 0.1 X 200 ml/min = 20 ml/min b. CLH’ = QH’  EH = 1.2 L/min x 0.007 = 8.4 ml/min 4

In an average 70-kg adult, Drug D is completely absorbed into the intestinal epithelium following oral administration and does not undergo intestinal metabolism. The oral bioavailability of Drug D is 25%. If the protein binding of the drug is decreased from 99% to 98%, what is the new oral bioavailability? F = 0.25, fu = 0.01 EH = 1-F = 0.75 Drug D is a high extraction ratio drug. fu’=0.02, fu’/fu = 2, i.e. the free fraction increases by 2 fold F’ = F/2 = 12.5% i.e. the new bioavailability decreases by a half.

Drug E is a low extraction ratio drug In an average 70-kg adult, Drug E is completely absorbed into the intestinal epithelium following oral administration and does not undergo intestinal metabolism. The oral bioavailability of Drug E is 75%. If the protein binding of the drug is decreased from 99% to 98%, what is the new oral bioavailability? F = 0.75, fu = 0.01 EH = 1-F = 0.25 Drug E is a low extraction ratio drug Even though fu’=0.02, fu’/fu = 2, i.e. the free fraction increases by 2 fold F’ = F = 75% i.e. the bioavailability is insensitive to changes in fu 6

CLT = Ro/Css = (100 mg/h)/(20mg/L) =5 L/h Drug F is administered via intravenous infusion to a patient at a rate of 100 mg/h for 10 hours. The steady-state plasma drug concentration is 20 mg/L, a total of 300 mg of the drug is excreted unchanged in the urine. Drug F is only eliminated via renal excretion and hepatic metabolism. What is the total clearance (CLT), renal clearance (CLR) and hepatic clearance (CLH)? CLT = Ro/Css = (100 mg/h)/(20mg/L) =5 L/h fe = excreted unchanged in the urine/IV dose = 300 mg / (100 mg/h X 10 h) = 0.3 CLR = fe · CLT = 0.3 X 5 L/h = 1.5 L/h CLH = CLT - CLR = 3.5 L/h 7

In an average 70-kg adult, intravenous Drug G is eliminated by renal excretion only. When Drug G is given as i.v. infusion at 1 mg/min, an steady-state plasma concentration of 10 mg/L (fu =0.1) is achieved. a) What is the renal clearance of Drug G? CLR= CLT = Ro/Css = (1mg/min)/(10 mg/L) = 0.1 L/min = 100 ml/min CLR = fu GFR + (CLtubular secretion – CLtubular reabsorption) fu GFR = 0.1 X 120 ml/min =12 ml/min CLR > fu GFR, there is a net tubular secretion of 88 ml/min

b) If the plasma protein binding of Drug G is decreased to 80%, what is the new renal clearance of Drug G? Assume no saturation in tubular secretion or reabsorption. CLR = fu GFR + (CLtubular secretion – CLtubular reabsorption) = 0.2 X 120 ml/min + 88 ml/min = 112 ml/min